HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 24, No. 12, December 2020 – A year of the COVID-19 Pandemic: Preparing for What’s Nex       » Tencent Launches New Products to Enhance Medical Imaging Management       » Learning how to Save Energy from Schooling Fish       » Pfizer and BioNTech Announce Successful Interim Analysis from COVID-19 Vaccine Phase 3 Study       » Producing Environmentally Friendly Plastic Bags       » New study shows mothers pass on allergies to offspring in the womb      
Vol 24, No. 10, October 2020   |   Issue PDF view/purchase
EDITOR'S LETTER
Artificial Intelligence Helping to Tide over the Pandemic

Early concepts of artificial intelligence dates back to ancient history where ideas of bestowing man-made beings with the ability to have its own consciousness to make decisions and process information. It was not until the 1950s when technology caught up and the field of artificial intelligence research was founded during a conference at the Dartmouth College in 1956.

Fast forward more than 60 years later, artificial intelligence technologies have been applied to many things we use in our daily lives. These range from social media application to using artificial intelligence for processing data to understand patterns in trends in solving issues in transportation. Other examples of everyday applications of artificial intelligence include, email spam filters, plagiarism checkers, and financial transactions. Various forms of artificial intelligence technologies have benefitted a number of industries in helping to process large amounts of data to generate useful insights or identify patterns that could be used to make improvements.

As quoted from Ginni Rometty, who was IBM’s CEO from 2012 to 2020, “Some people call this artificial intelligence, but the reality is this technology will enhance us. So instead of artificial intelligence, I think we'll augment our intelligence.” It is no doubt that artificial intelligence has already been helping us in a number of ways, with the recent COVID-19 pandemic it has also been able to shine in this area to assist in managing this outbreak.

In the Features for this month of October, we have an article contribution on how artificial intelligence is helping to combat the COVID-19 outbreak. (p. 18) Also, we explore the paradigm shifting use of artificial intelligence in accelerating the drug discovery process. (p. 22)

Turning to the Spotlights section, we keep things close to our heart with an article on the clinical trial by Boehringer Ingelheim and Eli Lilly and Company, that discovered the use of a diabetes medication for treating heart failure. (p. 26) Looking towards the future of research in heart disease, we dive into the work of researchers who are creating a genetic and cellular map of the human heart to better understand disease pathogenesis. (p. 32)

Finally, in the Columns section, we come back to the most pressing story of the year 2020, the COVID-19 pandemic. This month we gather an understanding of what would it take to develop the COVID-19 vaccine at an accelerated pace. (p. 14)


Deborah Emmanuel SEAH Qing En
Editor
You can reach me at qeseah@wspc.com

 

You can always access all APBN's issues on our website: www.asiabiotech.com.
Check us out at Facebook @Asia Pacific Biotech News, Instagram @asiabiotech, or follow us on Twitter @asia_biotech.

 

NEWS CRUNCH  
news Highlights from the E&L China 2020 Conference
news Asia’s ageing population drives development of rehabilitation technologies targeting elderly disabilities
news Virtual Expo Connect to empower access for international pharma to the world’s largest pharma ingredients market
news WEIPU, AstraZeneca, Huadong Medicine, Saint-Gobain, Baxter, Wuxi AppTec, Henlius, Medtronic and more confirmed to speak at E&L China this December
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2021 World Scientific Publishing Co Pte Ltd  •  Privacy Policy